FI20041204A0 - Menetelmät immuunivälitteisiin sairauksiin liittyvien uusien kohdegeenien hyödyntämiseksi - Google Patents

Menetelmät immuunivälitteisiin sairauksiin liittyvien uusien kohdegeenien hyödyntämiseksi

Info

Publication number
FI20041204A0
FI20041204A0 FI20041204A FI20041204A FI20041204A0 FI 20041204 A0 FI20041204 A0 FI 20041204A0 FI 20041204 A FI20041204 A FI 20041204A FI 20041204 A FI20041204 A FI 20041204A FI 20041204 A0 FI20041204 A0 FI 20041204A0
Authority
FI
Finland
Prior art keywords
immune
utilization
methods
target genes
new target
Prior art date
Application number
FI20041204A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Inventor
Riikka Lund
Riitta Lahesmaa
Original Assignee
Riikka Lund
Riitta Lahesmaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riikka Lund, Riitta Lahesmaa filed Critical Riikka Lund
Priority to FI20041204A priority Critical patent/FI20041204A0/fi
Publication of FI20041204A0 publication Critical patent/FI20041204A0/fi
Priority to PCT/FI2005/050320 priority patent/WO2006030071A2/en
Priority to EP05787813A priority patent/EP1794315A4/de
Priority to US11/662,878 priority patent/US7989172B2/en
Priority to EP10162955A priority patent/EP2386653A3/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI20041204A 2004-09-16 2004-09-16 Menetelmät immuunivälitteisiin sairauksiin liittyvien uusien kohdegeenien hyödyntämiseksi FI20041204A0 (fi)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FI20041204A FI20041204A0 (fi) 2004-09-16 2004-09-16 Menetelmät immuunivälitteisiin sairauksiin liittyvien uusien kohdegeenien hyödyntämiseksi
PCT/FI2005/050320 WO2006030071A2 (en) 2004-09-16 2005-09-16 Methods for the utilization of novel target genes related to immune-mediated diseases
EP05787813A EP1794315A4 (de) 2004-09-16 2005-09-16 Verfahren zur nutzung neuer zielgene in verbindung mit immunvermittelten krankheiten
US11/662,878 US7989172B2 (en) 2004-09-16 2005-09-16 Method of identifying a compound capable of modulating the Th2 polarization of CD4+ lymphocytes
EP10162955A EP2386653A3 (de) 2004-09-16 2005-09-16 Verfahren zur Verwendung neuer Target-Gene, die im Zusammenhang mit immunvermittelten Krankheiten stehen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20041204A FI20041204A0 (fi) 2004-09-16 2004-09-16 Menetelmät immuunivälitteisiin sairauksiin liittyvien uusien kohdegeenien hyödyntämiseksi

Publications (1)

Publication Number Publication Date
FI20041204A0 true FI20041204A0 (fi) 2004-09-16

Family

ID=33041540

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20041204A FI20041204A0 (fi) 2004-09-16 2004-09-16 Menetelmät immuunivälitteisiin sairauksiin liittyvien uusien kohdegeenien hyödyntämiseksi

Country Status (4)

Country Link
US (1) US7989172B2 (de)
EP (2) EP1794315A4 (de)
FI (1) FI20041204A0 (de)
WO (1) WO2006030071A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090156540A1 (en) * 2006-03-07 2009-06-18 Mckenna Katherine Method for diagnosing and/or predicting the development of an allergic disorder and agents for treating and/or preventing same

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4704362A (en) 1977-11-08 1987-11-03 Genentech, Inc. Recombinant cloning vehicle microbial polypeptide expression
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US4987071A (en) 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
US5132405A (en) 1987-05-21 1992-07-21 Creative Biomolecules, Inc. Biosynthetic antibody binding sites
US5091513A (en) 1987-05-21 1992-02-25 Creative Biomolecules, Inc. Biosynthetic antibody binding sites
US5001065A (en) 1987-05-27 1991-03-19 Cetus Corporation Human cell line and triomas, antibodies, and transformants derived therefrom
JPS6412935A (en) 1987-07-02 1989-01-17 Mitsubishi Electric Corp Constant-speed travel device for vehicle
IL162181A (en) 1988-12-28 2006-04-10 Pdl Biopharma Inc A method of producing humanized immunoglubulin, and polynucleotides encoding the same
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US5424186A (en) 1989-06-07 1995-06-13 Affymax Technologies N.V. Very large scale immobilized polymer synthesis
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
EP0562025B1 (de) 1990-12-06 2001-02-07 Affymetrix, Inc. (a Delaware Corporation) Verbindungen und ihre Verwendung in einer binären Synthesestrategie
US5384261A (en) 1991-11-22 1995-01-24 Affymax Technologies N.V. Very large scale immobilized polymer synthesis using mechanically directed flow paths
ATE262374T1 (de) 1991-11-22 2004-04-15 Affymetrix Inc Kombinatorische strategien für polymersynthese
US5426039A (en) 1993-09-08 1995-06-20 Bio-Rad Laboratories, Inc. Direct molecular cloning of primer extended DNA containing an alkane diol
AU8126694A (en) 1993-10-26 1995-05-22 Affymax Technologies N.V. Arrays of nucleic acid probes on biological chips
US5571639A (en) 1994-05-24 1996-11-05 Affymax Technologies N.V. Computer-aided engineering system for design of sequence arrays and lithographic masks
US5795716A (en) 1994-10-21 1998-08-18 Chee; Mark S. Computer-aided visualization and analysis system for sequence evaluation
US5599695A (en) 1995-02-27 1997-02-04 Affymetrix, Inc. Printing molecular library arrays using deprotection agents solely in the vapor phase
US6066322A (en) 1995-03-03 2000-05-23 Millennium Pharmaceuticals, Inc. Methods for the treatment of immune disorders
JP2000504575A (ja) 1996-02-08 2000-04-18 アフィメトリックス，インコーポレイテッド 微生物のチップベースの種分化および表現型特徴付け
GB9710475D0 (en) 1997-05-21 1997-07-16 Zeneca Ltd Gene silencing
US6333155B1 (en) 1997-12-19 2001-12-25 Affymetrix, Inc. Exploiting genomics in the search for new drugs
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
WO1999053050A1 (en) 1998-04-08 1999-10-21 Commonwealth Scientific And Industrial Research Organisation Methods and means for obtaining modified phenotypes
CA2326827A1 (en) * 1998-05-05 1999-11-11 Gene Logic, Inc. A process to study changes in gene expression in t lymphocytes
EP1147204A1 (de) 1999-01-28 2001-10-24 Medical College Of Georgia Research Institute, Inc. Zusammensetzung und verfahren zur in vivo und in vitro abschwächung der genexpression mittels dobbelsträngigem rna
US8048672B2 (en) 1999-06-02 2011-11-01 President And Fellows Of Harvard College T-bet compositions and methods of use thereof
GB9927444D0 (en) 1999-11-19 2000-01-19 Cancer Res Campaign Tech Inhibiting gene expression
KR20080023768A (ko) 2000-03-30 2008-03-14 화이트헤드 인스티튜트 포 바이오메디칼 리서치 Ｒｎａ 간섭의 ｒｎａ 서열 특이적인 매개체
WO2001079555A2 (en) 2000-04-14 2001-10-25 Millennium Pharmaceuticals, Inc. Roles of jak/stat family members in tolerance induction
JP2005527179A (ja) * 2000-05-18 2005-09-15 ジェネティクス インスティテュート，エルエルシー Ｔヘルパー−１細胞及びｔヘルパー−２細胞並びにそれらに関連する疾患を確認及び調節するための組成物、キット、及び方法
WO2002028999A2 (en) 2000-10-03 2002-04-11 Gene Logic, Inc. Gene expression profiles in granulocytic cells
CZ302719B6 (cs) 2000-12-01 2011-09-21 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Izolovaná molekula dvouretezcové RNA, zpusob její výroby a její použití
US20030099963A1 (en) * 2000-12-22 2003-05-29 Morris David W. Novel compositions and methods in cancer associated with altered expression of TBX21
AU2002253878A1 (en) 2001-01-25 2002-08-06 Gene Logic, Inc. Gene expression profiles in breast tissue
US20070020637A1 (en) 2003-01-21 2007-01-25 Research Association For Biotechnology Full-length cDNA
EP1440981A3 (de) 2003-01-21 2005-11-23 Research Association for Biotechnology Vollständige humane cDNS
US7659077B2 (en) 2003-03-17 2010-02-09 Riikka Lund Methods utilizing target genes related to immune-mediated diseases
WO2005019258A2 (en) * 2003-08-11 2005-03-03 Genentech, Inc. Compositions and methods for the treatment of immune related diseases

Also Published As

Publication number Publication date
US20080168570A1 (en) 2008-07-10
EP1794315A4 (de) 2009-11-18
EP1794315A2 (de) 2007-06-13
US7989172B2 (en) 2011-08-02
WO2006030071A3 (en) 2006-05-04
EP2386653A2 (de) 2011-11-16
WO2006030071A2 (en) 2006-03-23
EP2386653A3 (de) 2012-02-22

Similar Documents

Publication Publication Date Title
DE602005027253D1 (de) Herbizidresistenz verleihende gene
DK1957528T3 (da) Nukleotid-vaccine
BRPI0811755A2 (pt) Amplificação específica de senquência de dna específicas de tumor.
CY2016054I2 (el) Κιναση της θυμιδινης
DE102006052908A8 (de) Wafer-Auffang-Vorrichtung
FI20041204A0 (fi) Menetelmät immuunivälitteisiin sairauksiin liittyvien uusien kohdegeenien hyödyntämiseksi
FI7074U1 (fi) Aseen tukki
FI20045252A (fi) AV-järjestelmä sekä ohjain
SE0701835L (sv) Trådlöst system för parkeringsavgifter eller liknande
FI20061156A0 (fi) Uusia peptidejä
ITTO20060063A1 (it) Corredo per l'amplificazione di acidi nucleici.
DE502004010807D1 (de) Auftragskopf
FI7550U1 (fi) Savupiipun juuripelti
ITVI20050291A1 (it) Forno per la cottura di laterizi
SE0400037D0 (sv) Förfarande för uppförande av hus
TH91487B (th) กระเบื้องหลังคาระบายความร้อนด้วยตัวเองโดยอากาศไหลผ่านภายในตัวกระเบื้อง
FI20040897A0 (fi) Uusia probiooteja
SE0401820D0 (sv) Primerprober för snabb realtids PCR
ES1058498Y (es) Sistema modular de construccion de luminarias.
SE0403150D0 (sv) Target
FI20040060A (fi) Lämmönsiirtojärjestelmän ohjaaminen
SE0601095L (sv) Nya formler för böjmoment
ITTO20050198A1 (it) Sistema per la protezione dellepiastrelle del piano cottura
ITBO20060639A1 (it) Stampo per la fabbricazione di piastrelle ceramiche.
FI20041143A0 (fi) Teline ilotulitusrakettien laukaisemiseksi

Legal Events

Date Code Title Description
FD Application lapsed